Position in PFE
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$112,068
-$18,616 QoQ
Shares Held
4,654
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#2,526
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Canton Hathaway, LLC holds $4,383,166 across 9 Drug Manufacturers - General names. PFE ranks #6 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
7,075 | $1,796,837 | |
| 2 | LLY |
ELI LILLY & Co
|
873 | $1,047,102 | |
| 3 | MRK |
Merck & Co., Inc.
|
5,898 | $757,893 | |
| 4 | ABBV |
AbbVie Inc.
|
1,326 | $333,674 | |
| 5 | AMGN |
Amgen Inc
|
515 | $186,491 | |
| 6 | PFE |
Pfizer Inc
This page
|
4,654 | $112,068 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
1,445 | $83,260 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
345 | $43,587 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $112,068 | 4,654 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $130,684 | 4,654 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $93,474 | 3,754 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $90,555 | 3,554 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $86,148 | 3,554 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $78,021 | 3,079 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $81,685 | 3,079 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $334,372 | 11,554 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $323,280 | 11,554 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $292,873 | 10,554 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $217,479 | 7,554 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $84,716 | 2,554 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $72,296 | 1,971 | Shares | Sole | 2023-07-11 | |
| 2023-03-31 | $80,416 | 1,971 | Shares | Sole | 2023-04-11 | |
| 2022-12-31 | $100,994 | 1,971 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $84,500 | 1,931 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $145,807 | 2,781 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $143,972 | 2,781 | Shares | Sole | 2022-04-12 | |
| 2021-12-31 | $164,218 | 2,781 | Shares | Sole | 2022-01-06 | |
| 2021-09-30 | $119,610 | 2,781 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $71,897 | 1,836 | Shares | Sole | 2021-07-08 | |
| 2021-03-31 | $63,402 | 1,750 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $37,546 | 1,020 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $31,194 | 850 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $27,795 | 850 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $27,743 | 850 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||